Ausgabe 2/2014
Inhalt (23 Artikel)
Chikungunya in the Caribbean: An Epidemic in the Making
Lizette Mowatt, Sandra T. Jackson
A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii
Kimberly C. Claeys, Anna D. Fiorvento, Michael J. Rybak
Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV
Dorothy E. Dow, John A. Bartlett
Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral Therapy
Patrick G. Clay, Rustin D. Crutchley
Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE
Joseph J. Carreno, Thomas P. Lodise
Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review
Colleen Wegzyn, Lim Kai Toh, Gerard Notario, Sophie Biguenet, Kristina Unnebrink, Caroline Park, Doris Makari, Michael Norton
Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases
Tamara Bhandari, Victor Nizet
Pregnancy-Associated Severe Sepsis: Contemporary State and Future Challenges
Lavi Oud
Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Nancy W. Y. Leung, Eva Herrmann, George K. K. Lau, Henry L. Y. Chan, Tokutei M. K. So, Stefan Zeuzem, Yu Dong, Aldo Trylesinski, Nikolai V. Naoumov
Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation
Gabriel J. Robbie, Doris Makari, Brian Harris, Genevieve A. Losonsky, Hasan S. Jafri
Tolerability of High Doses of Daptomycin in the Treatment of Prosthetic Vascular Graft Infection: A Retrospective Study
Laurence Legout, Piervito D’Elia, Beatrice Sarraz-Bournet, Nicolas Ettahar, Stephan Haulon, Olivier Leroy, Eric Senneville
Effect of Concomitant 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor Therapy on Creatine Phosphokinase Levels and Mortality Among Patients Receiving Daptomycin: Retrospective Cohort Study
Heather L. McConnell, Elizabeth T. Perris, Colleen Lowry, Thomas Lodise, Nimish Patel
A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention
Laura Morata, Eric Senneville, Louis Bernard, Sophie Nguyen, Rodolphe Buzelé, Jérome Druon, Eduard Tornero, Josep Mensa, Alex Soriano
Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective Review
Kenneth V. I. Rolston, Lior Nesher, Jeffrey T. Tarrand
Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals
Kostas Athanasakis, Ioannis Petrakis, Mark Ollandezos, Christos Tsoulas, Dipen A. Patel, Eleftheria Karampli, John Kyriopoulos
Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI)
Wonhee So, Joseph L. Kuti, David P. Nicolau
Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficile
Bernadette Sewell, Eugene Rees, Ian Thomas, Chin Lye Ch’ng, Mike Isaac, Nidhika Berry
Point-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in Two Hospital Settings
Simon D. Goldenberg, Karen N. Bisnauthsing, Amita Patel, Anne Postulka, Duncan Wyncoll, Rebekah Schiff, Gary L. French
Necrotizing Fasciitis Associated with Pregnancy: a Population-Based Cohort Study
Lavi Oud, Phillip Watkins
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
Nicholas S. Britt, Molly E. Steed, Emily M. Potter, Lisa A. Clough
A Bad Case of Good’s Syndrome
Raffi Tachdjian, Janet J. Keller, Michael Pfeffer
Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity
Doris Makari, Kathryn M. Jensen, Brian Harris, Hasan S. Jafri
Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages
Milena M. McLaughlin, Erik Skoglund, Zachary Pentoney, Marc H. Scheetz